The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions
Clostridium Difficile InfectionC.Difficile DiarrheaCDI
Interventions
DRUG

Low Dose FMT Capsule DE

5 FMT Capsule DE along with antibiotic; followed by five capsules FMT Capsule DE x 7 days post-antibiotic course.

DRUG

Single Dose FMT Capsule DE

30 pill FMT Capsule DE treatment x 1, 48-72 hours following completion of antibiotic treatment.

DRUG

Placebo oral capsule

Five capsules per day along with antibiotic; followed by five capsules per day for seven days post-antibiotic treatment.

Trial Locations (1)

53794

University of Wisconsin Hospital & Clinics, Madison

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

University of Wisconsin, Madison

OTHER

NCT03621657 - The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation | Biotech Hunter | Biotech Hunter